IL33 and colonic neoplasm: We previously demonstrated that colon cancer cell-derived sST2 suppresses tumor growth by inhibiting the Th2 response, M2 macrophage polarization and tumor angiogenesis triggered by IL-33 in the tumor microenvironment [22].